203 related articles for article (PubMed ID: 33586680)
1. Aberrant AZIN2 and polyamine metabolism precipitates tau neuropathology.
Sandusky-Beltran LA; Kovalenko A; Placides DS; Ratnasamy K; Ma C; Hunt JB; Liang H; Calahatian JIT; Michalski C; Fahnestock M; Blair LJ; Darling AL; Baker JD; Fontaine SN; Dickey CA; Gamsby JJ; Nash KR; Abner E; Selenica MB; Lee DC
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33586680
[TBL] [Abstract][Full Text] [Related]
2. Spermidine/spermine-N
Sandusky-Beltran LA; Kovalenko A; Ma C; Calahatian JIT; Placides DS; Watler MD; Hunt JB; Darling AL; Baker JD; Blair LJ; Martin MD; Fontaine SN; Dickey CA; Lussier AL; Weeber EJ; Selenica MB; Nash KR; Gordon MN; Morgan D; Lee DC
Alzheimers Res Ther; 2019 Jun; 11(1):58. PubMed ID: 31253191
[TBL] [Abstract][Full Text] [Related]
3. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
4. Brain neurons express ornithine decarboxylase-activating antizyme inhibitor 2 with accumulation in Alzheimer's disease.
Mäkitie LT; Kanerva K; Polvikoski T; Paetau A; Andersson LC
Brain Pathol; 2010 May; 20(3):571-80. PubMed ID: 19832840
[TBL] [Abstract][Full Text] [Related]
5. Antizyme inhibitor 2: molecular, cellular and physiological aspects.
López-Contreras AJ; Ramos-Molina B; Cremades A; Peñafiel R
Amino Acids; 2010 Feb; 38(2):603-11. PubMed ID: 19956990
[TBL] [Abstract][Full Text] [Related]
6. Expression of antizyme inhibitor 2 in mast cells and role of polyamines as selective regulators of serotonin secretion.
Kanerva K; Lappalainen J; Mäkitie LT; Virolainen S; Kovanen PT; Andersson LC
PLoS One; 2009 Aug; 4(8):e6858. PubMed ID: 19718454
[TBL] [Abstract][Full Text] [Related]
7. Altered Brain Arginine Metabolism and Polyamine System in a P301S Tauopathy Mouse Model: A Time-Course Study.
Mein H; Jing Y; Ahmad F; Zhang H; Liu P
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682712
[TBL] [Abstract][Full Text] [Related]
8. Activity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brain.
Wheeler JM; McMillan P; Strovas TJ; Liachko NF; Amlie-Wolf A; Kow RL; Klein RL; Szot P; Robinson L; Guthrie C; Saxton A; Kanaan NM; Raskind M; Peskind E; Trojanowski JQ; Lee VMY; Wang LS; Keene CD; Bird T; Schellenberg GD; Kraemer B
Sci Transl Med; 2019 Dec; 11(523):. PubMed ID: 31852801
[TBL] [Abstract][Full Text] [Related]
9. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751
[TBL] [Abstract][Full Text] [Related]
10. New insights of polyamine metabolism in testicular physiology: A role of ornithine decarboxylase antizyme inhibitor 2 (AZIN2) in the modulation of testosterone levels and sperm motility.
Lambertos A; Ramos-Molina B; López-Contreras AJ; Cremades A; Peñafiel R
PLoS One; 2018; 13(12):e0209202. PubMed ID: 30566531
[TBL] [Abstract][Full Text] [Related]
11. Sustained Arginase 1 Expression Modulates Pathological Tau Deposits in a Mouse Model of Tauopathy.
Hunt JB; Nash KR; Placides D; Moran P; Selenica ML; Abuqalbeen F; Ratnasamy K; Slouha N; Rodriguez-Ospina S; Savlia M; Ranaweera Y; Reid P; Dickey CA; Uricia R; Yang CG; Sandusky LA; Gordon MN; Morgan D; Lee DC
J Neurosci; 2015 Nov; 35(44):14842-60. PubMed ID: 26538654
[TBL] [Abstract][Full Text] [Related]
12. The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation.
Yang YY; Ren YT; Jia MY; Bai CY; Liang XT; Gao HL; Zhong ML; Wang T; Guo C
Exp Neurol; 2023 Apr; 362():114346. PubMed ID: 36750170
[TBL] [Abstract][Full Text] [Related]
13. Antizyme inhibitor 2 (AZIN2/ODCp) stimulates polyamine uptake in mammalian cells.
López-Contreras AJ; Ramos-Molina B; Cremades A; Peñafiel R
J Biol Chem; 2008 Jul; 283(30):20761-9. PubMed ID: 18508777
[TBL] [Abstract][Full Text] [Related]
14. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal tau oligomerization early in tau pathology coincides with a transient alteration of mitochondrial homeostasis and DNA repair in a mouse model of tauopathy.
Zheng J; Akbari M; Schirmer C; Reynaert ML; Loyens A; Lefebvre B; Buée L; Croteau DL; Galas MC; Bohr VA
Acta Neuropathol Commun; 2020 Mar; 8(1):25. PubMed ID: 32131898
[TBL] [Abstract][Full Text] [Related]
16. Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
Przybyla M; van Eersel J; van Hummel A; van der Hoven J; Sabale M; Harasta A; Müller J; Gajwani M; Prikas E; Mueller T; Stevens CH; Power J; Housley GD; Karl T; Kassiou M; Ke YD; Ittner A; Ittner LM
Brain; 2020 Jun; 143(6):1889-1904. PubMed ID: 32375177
[TBL] [Abstract][Full Text] [Related]
17. Ornithine decarboxylase antizyme inhibitor 2 regulates intracellular vesicle trafficking.
Kanerva K; Mäkitie LT; Bäck N; Andersson LC
Exp Cell Res; 2010 Jul; 316(11):1896-906. PubMed ID: 20188728
[TBL] [Abstract][Full Text] [Related]
18. Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum.
Andrés-Benito P; Carmona M; Jordán M; Fernández-Irigoyen J; Santamaría E; Del Rio JA; Ferrer I
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054902
[TBL] [Abstract][Full Text] [Related]
19. Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology.
Hochgräfe K; Sydow A; Mandelkow EM
FEBS J; 2013 Sep; 280(18):4371-81. PubMed ID: 23517246
[TBL] [Abstract][Full Text] [Related]
20. Altered brain arginine metabolism in a mouse model of tauopathy.
Vemula P; Jing Y; Zhang H; Hunt JB; Sandusky-Beltran LA; Lee DC; Liu P
Amino Acids; 2019 Mar; 51(3):513-528. PubMed ID: 30604097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
